Susanna Ricci Selected Research

batimastat (BB 94)

7/2020	Combined therapy with ceftriaxone and doxycycline does not improve the outcome of meningococcal meningitis in mice compared to ceftriaxone monotherapy.
12/2014	Inhibition of matrix metalloproteinases attenuates brain damage in experimental meningococcal meningitis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Susanna Ricci Research Topics

Disease

7	Infections 12/2014 - 05/2004
4	Meningitis 01/2019 - 09/2004
4	Sepsis (Septicemia) 01/2012 - 05/2004
3	Meningococcal Meningitis 07/2020 - 12/2014
3	Pneumococcal Meningitis (Streptococcus pneumoniae Meningitis) 07/2020 - 09/2004
2	Brain Injuries (Brain Injury) 07/2020 - 12/2014
2	Pneumococcal Infections 10/2008 - 09/2006
1	Fibromyalgia (Fibrositis) 01/2023
1	Obesity 01/2023
1	Infertility (Sterility) 01/2022
1	Weight Loss (Weight Reduction) 01/2021
1	Hemorrhage 12/2014
1	Encephalitis (Encephalitis, Rasmussen) 09/2013
1	Communicable Diseases (Infectious Diseases) 10/2008
1	Pneumonia (Pneumonitis) 09/2006
1	Bacterial Meningitis 09/2004
1	Body Weight (Weight, Body) 09/2003
1	Ulcerative Colitis 09/2003
1	Inflammation (Inflammations) 09/2003

Drug/Important Bio-Agent (IBA)

5	VaccinesIBA 01/2012 - 09/2004
2	Matrix Metalloproteinases (MMPs)IBA 07/2020 - 12/2014
2	batimastat (BB 94)IBA 07/2020 - 12/2014
2	Proteins (Proteins, Gene)FDA Link 06/2013 - 01/2012
2	Anti-Bacterial Agents (Antibiotics)IBA 10/2008 - 09/2004
2	Peptides (Polypeptides)IBA 09/2006 - 12/2004
1	4-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA 01/2023
1	AminoglycosidesIBA 01/2022
1	Matrix Metalloproteinase InhibitorsIBA 07/2020
1	Ceftriaxone (Ceftriaxon)FDA LinkGeneric 07/2020
1	Doxycycline (Periostat)FDA LinkGeneric 07/2020
1	Tetracycline (Achromycin)FDA LinkGeneric 07/2020
1	Neuroprotective AgentsIBA 07/2020
1	Sialic AcidsIBA 01/2019
1	N-Acetylneuraminic Acid (Sialic Acid)IBA 01/2019
1	Biomarkers (Surrogate Marker)IBA 12/2014
1	Virulence Factors (Pathogenicity Factors)IBA 09/2013
1	Capsules (Microcapsules)IBA 09/2013
1	CarbonIBA 01/2012
1	AntigensIBA 10/2011
1	Complement Factor H (Factor H)IBA 10/2011
1	AntioxidantsIBA 09/2009
1	Glutathione (Reduced Glutathione)IBA 09/2009
1	Glutamic Acid (Glutamate)FDA Link 09/2009
1	ElementsIBA 10/2008
1	Pneumococcal Vaccines (Pneumococcal Polysaccharide Vaccine)IBA 10/2008
1	Bacterial AntigensIBA 09/2006
1	Metalloproteases (Metalloproteinases)IBA 09/2006
1	Streptococcus pneumoniae plY proteinIBA 09/2006
1	Membrane Proteins (Integral Membrane Proteins)IBA 05/2004
1	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 09/2003
1	Interleukin-2 (IL2)IBA 09/2003
1	Interleukin-1 (Interleukin 1)IBA 09/2003

Therapy/Procedure

2	Therapeutics 07/2020 - 09/2004
1	Ketogenic Diet 01/2023
1	Bariatric Surgery 01/2021